Health Care: Drugs

Merrimack Pharmaceuticals Inc (MACK: NASDAQ)

$5.5 n/a | n/a%
07/22/16 - 04:00 PM ET
Latest Dividend:0
Latest Dividend Yield:0%
Dividend Ex-Date:12/31/69
Price Earnings Ratio:n/a
Price Earnings Comparisons:
MACKSector Avg.S&P 500
n/a012.9
Price Performance History (% change):
3 Mo1 Yr3 Yr
-27.3448-47.267514.3451
GROWTH12 Mo3 YrCAGR
Revenue-13.10.80.22
Net Income0.60
EPS0n/a
Earnings for MACK:
EBITDA-129.00
REVENUE89.26M
Average Earnings Estimates
Qtr (06/16) Qtr (09/16) FY (12/16) FY (12/17)
Average Estimate $-0.34 $0.01 $-0.78 $-0.43
Number of Analysts 2 1 3 3
High Estimate $-0.31 $0.01 $-0.71 $-0.19
Low Estimate $-0.37 $0.01 $-0.87 $-0.59
Prior Year $-0.21 $-0.38 $-1.33 $-0.78
Growth Rate (Year over Year) -61.90% 102.63% 41.10% 45.53%

Portfolios with MACK

Latest MACK Headlines from TheStreet

More Financial News for MACK

Press Releases for MACK

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter